(Q33360118)

26 July 2017

1 reference

title

Measurement of bleeding severity: a critical review (English)

1 reference

26 July 2017

Rachel Koreth

1

1 reference

26 July 2017

Craig Weinert

series ordinal

2

1 reference

26 July 2017

Daniel J Weisdorf

series ordinal

3

1 reference

26 July 2017

Nigel S Key

series ordinal

4

1 reference

26 July 2017

publication date

1 April 2004

1 reference

26 July 2017

1 reference

26 July 2017

volume

44

1 reference

26 July 2017

issue

4

1 reference

26 July 2017

page(s)

605-617

1 reference

Acute bleeding after allogeneic bone marrow transplantation: association with graft versus host disease and effect on survival

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.03153.X

Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.03153.X

The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.03153.X

Grading of hemorrhage in children with idiopathic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.03153.X

Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.03153.X

Treatment protocols in The Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.03153.X

The use of porcine factor VIII concentrate (Hyate:C) in the treatment of patients with inhibitor antibodies to factor VIII. A multicenter US experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.03153.X

Joint evaluation instruments for children and adults with haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.03153.X

MRI findings in haemophilic joints treated with radiosynoviorthesis with development of an MRI scale of joint damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.03153.X

Safety observations from the pilot phase of the randomized r-Hirudin for Improvement of Thrombolysis (HIT-III) study. A study of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte (ALKK)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.03153.X

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.03153.X

Hemorrhagic complications of long-term anticoagulant therapy for ischemic cerebral vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.03153.X

A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.03153.X

Duration of warfarin anticoagulant therapy and the probabilities of recurrent thromboembolism and hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.03153.X

Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.03153.X

Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.03153.X

Treatment of acute venous thromboembolism with low molecular weight heparin (Fragmin). Results of a double-blind randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.03153.X

Hemorrhagic Complications of Anticoagulant Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.03153.X

Management of anticoagulation in outpatients: experience with an anticoagulation service in a municipal hospital setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.03153.X

Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.03153.X

Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation: the AFASAK 2 study. Atrial Fibrillation Aspirin and Anticoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.03153.X

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.03153.X

Ximelagatran versus warfarin for the prevention of venous thromboembolism after total knee arthroplasty. A randomized, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.03153.X

Comparison of the oral direct thrombin inhibitor ximelagatran with enoxaparin as prophylaxis against venous thromboembolism after total knee replacement: a phase 2 dose-finding study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.03153.X

Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.03153.X

The Cause of Bleeding During Anticoagulant Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.03153.X

The significance of haemorrhage during the treatment of patients with the coumarin anticoagulants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.03153.X

Survival rates after acute myocardial infarction with long-term anticoagulant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.03153.X

The risk for and severity of bleeding complications in elderly patients treated with warfarin. The National Consortium of Anticoagulation Clinics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.03153.X

Problems associated with long-term anticoagulant therapy. Observations in 139 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.03153.X

The duration of oral anticoagulation after deep vein thrombosis. A randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.03153.X

Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.03153.X

Hirudin in acute myocardial infarction. Safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.03153.X

The bleeding severity index: validation and comparison to other methods for classifying bleeding complications of medical therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.03153.X

A bleeding risk index for estimating the probability of major bleeding in hospitalized patients starting anticoagulant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.03153.X

Identification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.03153.X

Studies with different types of visual analog scales for measurement of pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2004.03153.X

10.1111/J.1537-2995.2004.03153.X

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference